Skip to content

Absci Corporation ABSI Additional Paid-In Capital

Additional Paid-In Capital at other companies

Schrodinger logo
SchrodingerSDGR
$1B+4.6%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$3.19B+25.0%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$1.71B+27.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$196.62M+16.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$838.31M+0.7%
ADMA Biologics logo
ADMA BiologicsADMA
$649.8M-0.8%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's additional paid-in capital?
Absci Corporation (ABSI) reported additional paid-in capital of $826.04M in Q1 2026.
How has Absci Corporation's additional paid-in capital changed year-over-year?
Absci Corporation's additional paid-in capital increased by 12.4% year-over-year, from $734.71M to $826.04M.
What is the long-term trend for Absci Corporation's additional paid-in capital?
Over 5 years (2020 to 2025), Absci Corporation's additional paid-in capital has grown at a 318.3% compound annual growth rate (CAGR), from $635K to $813.63M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.